Cell-Surface Marker Signature for Enrichment of Ventricular Cardiomyocytes Derived from Human Embryonic Stem Cells

Autor: Nil Emre, Jeffrey M. Hegarty, Kirk U. Knowlton, Alec D. Witty, Canzhao Liu, Dekker C. Deacon, Kelly A. Frazer, Jason G. Vidal, Elie Farah, Karina Palomares, Sylvia M. Evans, Mirko Corselli, Christian T. Carson, Patrick van Vliet, Maggie Zhu, Ralf J. Dirschinger, Eric Adler, Jennifer Veevers, Kunfu Ouyang, Jonathan D. Grinstein, Neil C. Chi, Ju Chen, Jody Martin
Rok vydání: 2018
Předmět:
0301 basic medicine
Human Embryonic Stem Cells
Cell
cardiac differentiation
Regenerative Medicine
Cardiovascular
Biochemistry
Green fluorescent protein
Myocytes
Cardiac

cell-surface marker signature
Induced pluripotent stem cell
lcsh:QH301-705.5
Cells
Cultured

lcsh:R5-920
Cultured
Trihexosylceramides
Cell Differentiation
CD
Cell biology
Heart Disease
medicine.anatomical_structure
Development of treatments and therapeutic interventions
lcsh:Medicine (General)
Cardiac
Biotechnology
Myosin Light Chains
Myosin light-chain kinase
Heart Ventricles
Cells
1.1 Normal biological development and functioning
Transgene
Clinical Sciences
Biology
Cell Line
03 medical and health sciences
ventricular cardiomyocytes
Antigens
CD

Underpinning research
Genetics
medicine
Humans
Antigens
Stem Cell Research - Embryonic - Human
Myocytes
Bacterial artificial chromosome
5.2 Cellular and gene therapies
Cell Biology
Stem Cell Research
Embryonic stem cell
030104 developmental biology
MYL2
lcsh:Biology (General)
Biochemistry and Cell Biology
Cardiac Myosins
Developmental Biology
Zdroj: Stem cell reports, vol 11, iss 3
Stem Cell Reports, Vol 11, Iss 3, Pp 828-841 (2018)
ISSN: 2213-6711
Popis: Summary: To facilitate understanding of human cardiomyocyte (CM) subtype specification, and the study of ventricular CM biology in particular, we developed a broadly applicable strategy for enrichment of ventricular cardiomyocytes (VCMs) derived from human embryonic stem cells (hESCs). A bacterial artificial chromosome transgenic H9 hESC line in which GFP expression was driven by the human ventricular-specific myosin light chain 2 (MYL2) promoter was generated, and screened to identify cell-surface markers specific for MYL2-GFP-expressing VCMs. A CD77+/CD200− cell-surface signature facilitated isolation of >97% cardiac troponin I-positive cells from H9 hESC differentiation cultures, with 65% expressing MYL2-GFP. This study provides a tool for VCM enrichment when using some, but not all, human pluripotent stem cell lines. Tools generated in this study can be utilized toward understanding CM subtype specification, and enriching for VCMs for therapeutic applications. : In this article, Evans and colleagues generated an H9 BAC transgenic reporter cell line and performed a flow cytometry screen to identify a cell-surface signature specific for MYL2-GFP-expressing VCMs. The cell-surface signature, CD77+/CD200−, facilitated isolation of a nearly pure hESC-derived CM population, enriched for VCMs. VCM enrichment was achieved when using some, but not all, human pluripotent stem cell lines. Tools generated in this study serve to advance our understanding of CM subtype specification, commitment, and maturation. Keywords: cardiac differentiation, human embryonic stem cells, ventricular cardiomyocytes, cell-surface marker signature
Databáze: OpenAIRE